{"id":416066,"date":"2010-03-11T10:35:51","date_gmt":"2010-03-11T15:35:51","guid":{"rendered":"http:\/\/blogs.wsj.com\/health\/2010\/03\/11\/heart-roundup-device-maker-probes-too-many-angiograms\/"},"modified":"2010-03-11T10:35:51","modified_gmt":"2010-03-11T15:35:51","slug":"heart-roundup-device-maker-probes-too-many-angiograms","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/416066","title":{"rendered":"Heart Roundup: Device-Maker Probes, Too Many Angiograms"},"content":{"rendered":"<p><img decoding=\"async\" src=\"http:\/\/s.wsj.net\/media\/heart_art_200_20071214093616.jpg\" alt=\"heart\" align=\"right\"\/>The <a href=\"http:\/\/www.acc.org\/thisweekatacc.htm#1\" >annual meeting<\/a> of the American College of Cardiology gets underway this weekend and some heart-related items are in the news this morning:<\/p>\n<p><strong>Documents from leading medical-device makers<\/strong> suggest some companies seem to have encouraged the use of surgical ablation to treat atrial fibrillation, a <a href=\"http:\/\/online.wsj.com\/article\/SB10001424052748703414504575001220815778974.html\" >front-page article<\/a> in the WSJ reports. The problem, of course, is that the devices that can carefully destroy heart tissue linked to A-fib troubles aren&#8217;t FDA-approved for that purpose. A-fib is the most common type of <a href=\"http:\/\/blogs.wsj.com\/health\/2008\/10\/15\/atrial-fibrillation-the-cause-of-dick-cheneys-heart-trouble\/\" >faulty heartbeat<\/a>.<\/p>\n<p>The Justice Department is investigating and has won settlements with two lesser-known device makers. A former device saleswoman who brought those two cases has also sued Boston Scientific, Medtronic and St. Jude Medical. The DOJ hasn&#8217;t joined in those cases and the companies say none of their top execs were involved in any illegal marketing of the devices. More on the situation is <a href=\"http:\/\/online.wsj.com\/article\/SB122645554305019705-search.html?KEYWORDS=atricure&#038;COLLECTION=wsjie\/6month\" >here<\/a>.<\/p>\n<p><strong>Coronary angiograms, widely used tests<\/strong> to detect artery blockages in the heart, often turn up little or no evidence of disease, a study in the <a href=\"http:\/\/content.nejm.org\/cgi\/content\/short\/362\/10\/886\" >New England Journal of Medicine<\/a> found. That suggests that the more than a million U.S. patients who undergo the diagnostic test each year at a cost of about $10,000 each, are frequently exposed to unneeded risks of a costly procedure, the WSJ says in <a href=\"http:\/\/online.wsj.com\/article\/SB10001424052748704655004575114071378301774.html\" >another article<\/a>.<\/p>\n<p>The study of nearly 400,000 angiograms performed between 2004 and 2008 in the U.S. found that 62% of the patients didn&#8217;t have evidence of significant obstructions, while 38% had important blockages. Of course, a clean angiogram can still provide useful informaton and the findings don&#8217;t apply in cases when there is established heart disease or the threat of an imminent heart attack. Patients included in the study weren&#8217;t previously diagnosed with heart disease and represent about 20% of those who get angoigrams. <\/p>\n<p>Still, the data indicate overuse of angiograms. &#8220;We&#8217;ve got to get much smarter about how we&#8217;re ordering and interpreting these tests,&#8221; a Mayo Clinic cardiologist told the WSJ.<\/p>\n<p><em>Photo by  CarbonNYC via Flickr<\/em><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~at\/Fh21w2TIOw0rvhwVurRRUiCC-q0\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~at\/Fh21w2TIOw0rvhwVurRRUiCC-q0\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~at\/Fh21w2TIOw0rvhwVurRRUiCC-q0\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~at\/Fh21w2TIOw0rvhwVurRRUiCC-q0\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?a=Fjb-Nt80KP4:BiwTpyIAkmA:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?a=Fjb-Nt80KP4:BiwTpyIAkmA:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?i=Fjb-Nt80KP4:BiwTpyIAkmA:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?a=Fjb-Nt80KP4:BiwTpyIAkmA:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?i=Fjb-Nt80KP4:BiwTpyIAkmA:F7zBnMyn0Lo\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?a=Fjb-Nt80KP4:BiwTpyIAkmA:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?i=Fjb-Nt80KP4:BiwTpyIAkmA:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?a=Fjb-Nt80KP4:BiwTpyIAkmA:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/wsj\/health\/feed?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/wsj\/health\/feed\/~4\/Fjb-Nt80KP4\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The annual meeting of the American College of Cardiology gets underway this weekend and some heart-related items are in the news this morning: Documents from leading medical-device makers suggest some companies seem to have encouraged the use of surgical ablation to treat atrial fibrillation, a front-page article in the WSJ reports. The problem, of course, [&hellip;]<\/p>\n","protected":false},"author":792,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-416066","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/416066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/792"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=416066"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/416066\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=416066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=416066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=416066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}